aguea asia
Stefano Cafarotti
@SCafarotti
Joined April 2012
Tweets
34
Following
39
Followers
19
Likes
0
Photos and videos
Photos and videos
Tweets
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
2 May 2014
Most Popular: Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR-Mutated NSCLC: I...
bit.ly/PWswkJ
2
Stefano Cafarotti retweeted
Targeted Oncology
@TargetedOnc
2 May 2014
Ceritinib Approved by FDA for ALK-Positive NSCLC
targetedonc.com/articles/Cer…
3
Stefano Cafarotti retweeted
Medscape Oncology
@MedscapeOnc
2 May 2014
Ceritinib (Zykadia) - new drug for patients with ALK ve NSCLC who progress on crizotinib (Xalkori)
bit.ly/1rWUVFK
3
4
Stefano Cafarotti retweeted
Oncology Tube
@oncologytube
3 May 2014
Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes
fb.me/6tHiaGo79
3
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
21 Oct 2013
Most Popular: A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemot...
bit.ly/14ESzNh
4
2
Stefano Cafarotti retweeted
ESTS
@thoracic
7 Oct 2013
Welcome to our new followers, as
@thoracic
breaks the 200 followers barrier.
2
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
7 Oct 2013
Current ToC: Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Sta...
bit.ly/19xQm9l
2
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
8 Oct 2013
Ahead-of-Print: Radiotherapy for Intubated Patients with Malignant Airway Obstruction: Futile or Facilitating ...
bit.ly/19c0urC
2
Stefano Cafarotti retweeted
American Thoracic Society (ATS)
@atscommunity
8 Oct 2013
Combination maintenance therapy with erlotinib & bevacizumab offers little benefit for NSCLC patients:
ow.ly/pBD7W
4
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
8 Oct 2013
Current ToC: Acute Autoimmune Hepatitis, Myositis, and Myasthenic Crisis in a Patient with Thymoma: No abstrac...
bit.ly/1bWAeC2
1
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
7 Sep 2013
Ahead-of-Print: Screening High-Risk Populations for Lung Cancer: Guideline Recommendations: Introduction: The ...
bit.ly/1cQCxa4
3
2
Stefano Cafarotti
@SCafarotti
1 Sep 2013
journals.lww.com/jto/pages/a…
Stefano Cafarotti
@SCafarotti
1 Sep 2013
mobile.journals.lww.com/jto/…
Stefano Cafarotti
@SCafarotti
1 Sep 2013
mobile.journals.lww.com/jto/…
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
31 Aug 2013
Current ToC: Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non-Smal...
bit.ly/15HE00p
1
Stefano Cafarotti
@SCafarotti
1 Sep 2013
bit.ly/15HE00p
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
9 Jul 2013
Current ToC: Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Can...
bit.ly/1alVVOd
3
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
7 Jul 2013
Current ToC: Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked: Introduction: No clear data ...
bit.ly/154rXY0
3
Stefano Cafarotti retweeted
JTO & JTO CRR
@JTOonline
2 Jul 2013
Current ToC: Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identificat...
bit.ly/17F4Tll
6
1
Stefano Cafarotti retweeted
ESTS
@thoracic
14 Jun 2013
Just back from Birmingham? Our next annual conference 15th-18th June 2014 Copenhagen
2
1
Load more